Sartorius Stedim Biotech S.A. (FRA:56S1)
Germany flag Germany · Delayed Price · Currency is EUR
177.60
-3.20 (-1.77%)
At close: Feb 20, 2026

Sartorius Stedim Biotech Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
265.6175.1310.3876.1414.4
Depreciation & Amortization
265.8259.5213.2162.3126.4
Other Amortization
52.342.223.619.415.2
Loss (Gain) on Equity Investments
2.28.6---
Other Operating Activities
131.778.78.6-94.2291.6
Change in Accounts Receivable
42.938.3162.1-65.8-87.3
Change in Inventory
-46.4207.6131.2-217.9-275.4
Change in Other Net Operating Assets
-21.95.1-102.6-67.6217
Operating Cash Flow
692.2815.1746.4612.3701.9
Operating Cash Flow Growth
-15.08%9.20%21.90%-12.77%68.37%
Capital Expenditures
-393.2-339.8-473.6-430.6-324
Cash Acquisitions
---2,241-515.6-141.7
Investment in Securities
-4.4-0.1-8.1--
Other Investing Activities
-0.1-0.1-0.1-11.30.5
Investing Cash Flow
-397.7-340-2,723-957.5-465.2
Long-Term Debt Issued
13.317.32,649566.874.2
Long-Term Debt Repaid
-334.8-879.2-326.4-174.4-79.7
Net Debt Issued (Repaid)
-321.5-861.92,323392.4-5.5
Issuance of Common Stock
0.21,1941.3--
Repurchase of Common Stock
--1.9--3.2-
Common Dividends Paid
-67.1-67.1-132.7-116.1-62.7
Other Financing Activities
-154.4-177.8-205.3-52.4-9.5
Financing Cash Flow
-542.884.91,986220.7-77.7
Foreign Exchange Rate Adjustments
-4.52.3-0.384.8
Net Cash Flow
-252.8562.39.5-116.5163.8
Free Cash Flow
299475.3272.8181.7377.9
Free Cash Flow Growth
-37.09%74.23%50.14%-51.92%46.65%
Free Cash Flow Margin
10.08%17.10%9.83%5.20%13.09%
Free Cash Flow Per Share
3.074.912.961.974.10
Cash Interest Paid
153.6176.9116.710.38.3
Cash Income Tax Paid
149.1133.5135.8221.2166.6
Levered Free Cash Flow
177.2369.881.0593.93425.14
Unlevered Free Cash Flow
263.51462.3153.18105.3431.51
Change in Working Capital
-25.4251190.7-351.3-145.7
Source: S&P Global Market Intelligence. Standard template. Financial Sources.